Method of Detection of Initial Recurrence of Stage II/III Cutaneous Melanoma: Analysis of the Utility of Follow-Up Staging
- 20 December 2008
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 16 (4) , 941-947
Abstract
The follow-up of patients with cutaneous melanoma is controversial. Current recommendations suggest routine history and physical examination every 3 to 6 months for the first 3 years and correlate studies including laboratory tests and radiographic imaging. However, the utility of these recommendations are unclear. The purpose of this study was to determine the impact of routine imaging on the method of detection of first recurrence in patients with stage II and sentinel lymph node-positive stage III melanoma. We analyzed a prospective database of all cutaneous melanoma patients treated at our institution from 1997 to 2005 who had at least 2 years of follow-up. The method of detection of initial recurrence was analyzed. One hundred eighteen patients with stage II (n = 83) or III (n = 35) melanoma who were followed for at least 2 years were identified. Forty-three of these patients developed recurrence (median time to recurrence, 14 months). Site of first recurrence was as follows: 4 local, 17 in transit, 7 regional lymph node, and 15 distant. Twenty-nine recurrences (67%) were either patient detected or symptomatic. Eleven (26%) were detected by the physician at routine follow-up. Only three (7%) were identified by imaging (two chest X-ray and one brain magnetic resonance imaging) in an otherwise asymptomatic patient. Two-thirds of all initial recurrences of cutaneous melanoma were either detected by a patient or were symptomatic, with most of the remainder detected during routine physical examination. Routine imaging added little value in the detection of initial recurrence.Keywords
This publication has 22 references indexed in Scilit:
- Prognosis and Determinants of Outcome Following Locoregional or Distant Recurrence in Patients with Cutaneous MelanomaAnnals of Surgical Oncology, 2008
- Role of radiologic imaging at the time of initial diagnosis of stage T1b‐T3b melanomaCancer, 2007
- Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2007
- Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up GuidelinesAnnals of Surgical Oncology, 2007
- The Conundrum of Follow-Up: Should it be Abandoned?Surgical Oncology Clinics of North America, 2006
- Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive PatientsJournal of Clinical Oncology, 2006
- Temozolomide in Combination With Interferon-Alfa Versus Temozolomide Alone in Patients With Advanced Metastatic Melanoma: A Randomized, Phase III, Multicenter Study from the Dermatologic Cooperative Oncology GroupJournal of Clinical Oncology, 2005
- A rational approach to melanoma follow-up in patients with primary cutaneous melanomaBritish Journal of Dermatology, 1999
- Favorable prognostic factors in recurrent and metastatic melanomaJournal of the American Academy of Dermatology, 1996
- Data on First Recurrence after Treatment for Malignant Melanoma in a Large Patient PopulationPlastic and Reconstructive Surgery, 1993